Treating human Metastatic cancers with an NIDDM drug: Acarbose, an α-glucosidase inhibitor, suppresses the expression of MMP-9 via up regulation of its target gene , 24/July/2014, 06.37 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Treating human Metastatic cancers with an NIDDM drug: Acarbose, an α-glucosidase inhibitor, suppresses the expression of MMP-9 via up regulation of its target gene , 24/July/2014, 06.37 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Web: http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation
Vitamins-based therapy for chemoresistant human cancers: δ-tocotrienol (a derivative of Vitamin-E) sensitizes chemoreistant cancer cells via down regulation of PEBP4, 24/July/2014, 06.35 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Vitamins-based therapy for chemoresistant human cancers: δ-tocotrienol (a derivative of Vitamin-E) sensitizes chemoreistant cancer cells via down regulation of PEBP4, 24/July/2014, 06.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Web: http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation
Physiological mechanisms that Control Gluconeogensis: The stem cell and reprogramming protein Oct-4 increases the expression of glucose-6-phosphatase (G6PC) via up regulation of its target gene, 23/July/2014, 05.19 am
A study from the Department of Biochemistry-Molecular Biology, Peking University Health Science Center, Beijing 100191, China has reported that “Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.” This study was published in the July 09, 2014 Proc Natl Acad Sci U S A. [I.F >10] by Prof. Zhu WG, Zhang P and others from the Department of Biochemistry-Molecular Biology, Peking University […]
Molecular therapy for bone-related disorders: Overexpression of Cell cycle-regulated protein E2F3 in human stromal cells increases bone formation via down regulation of its target gene, 23/July/2014, 05.03 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Molecular therapy for bone-related disorders: Overexpression of Cell cycle-regulated protein E2F3 in human stromal cells increases bone formation via down regulation of its target gene, 23/July/2014, 05.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Web: http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation
Natural product-based treatment for Cardiovascular disorders: Chaihuang-Yishen granule (CHYS) prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 05.00 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based treatment for Cardiovascular disorders: Chaihuang-Yishen granule (CHYS) prevents heart failure via down regulation of Type 5-cardiac adenylyl cyclase, 23/July/2014, 05.00 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Web: http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation
Molecular cancer therapy: ZIC1 increases the expression of CD107a/LAMP1 via down regulation of its target gene, 23/July/2014, 04.59 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L.,Molecular cancer therapy: ZIC1 increases the expression of CD107a/LAMP1 via down regulation of its target gene, 23/July/2014, 04,58 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Web: http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org